Precision medicine shows great potential in helping patients get personalized interventions for many conditions, said Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Precision medicine shows great potential in helping patients get personalized interventions for many conditions, said Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Transcript (slightly modified)
Will precision medicine be present in all disease states eventually, or are there some that won’t benefit from precision medicine?
There’s always going to be things, I think, where it doesn’t matter very much; might be because the agents we use to treat that condition would just be divided into children and adults and pretty much 100% of the children or adults given the right dose will respond. And those things will probably be down the path of time before they become part of the precision medicine initiative.
But there are others, all along the way there, that it will matter greatly to subdivide much more than just, a child gets this dose and an adult gets that dose, in terms of how much medicine somebody should get. There will be differences discovered in how they metabolize those medicines, absorb those medicines, how it impacts receptors in their body driven by their genetics mostly. And then there’ll be patients who don’t respond at all to some things, and will respond to others, and knowing which to use first is really delivering great care with great value, great triple aim.
And understanding that will come out of the precision medicine initiative of researching, do we have the right algorithm to analyze why should this person get a different intervention than that person? Based on their genetics, based on their social milieu, based on their comorbidities, and everything we put into that equation about what makes them unique.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More